Antibodies against human liver-specific protein (LSP) in acute and chronic viral heaptitis types A, B and non-A, non-B

R. Meliconi, M. Baraldini, G. F. Stefanini, A. Facchini, F. Miglio, F. Bortolotti, A. Alberti, G. Realdi, P. Amoroso

Research output: Contribution to journalArticle

Abstract

Sera from 42 patients with acute viral hepatitis (AVH), 97 patients with chronic active liver disease (CALD) and 89 controls were tested by radioimmunoprecipitation for the presence of antibodies against human liver-specific protein (LSP). Anti-LSP were found in all but one patient with AVH type A (93%) and in a smaller percentage of AVH type B (55%). In non-A, non-B cases, anti-LSP were found in low percentages: 27% in acute cases, 10% in chronic cases. Furthermore, in CALD, a significant difference was found between HBsAg-positive CAH and 'autoimmune' CAH, both in anti-LSP prevalence (21%, 67%; P <0.005) and in anti-LSP titre (1 : 154 ± 170; 1 : 316 ± 186; P <0.005). In HBsAg-negative/anti-HBc-positive CAH, three of 15 patients were anti-LSP positive. Anti-LSP were found only in three of 57 patients with various non-hepatic diseases with autoimmune features. None of the 12 healthy HBsAg carriers was positive. Hence there is evidence for a considerable heterogeneity in anti-LSP response in acute and in chronic inflammatory HBsAg-negative liver diseases. These data suggest that anti-LSP antibodies do not play a prominent role in the process of transition to chronicity of acute viral hepatitis particularly in non-A, non-B cases, whereas these antibodies may be important in the mechanism of ongoing liver cell injury in patients with 'autoimmune' CAH, and can represent a useful diagnostic marker of this type of hepatitis.

Original languageEnglish
Pages (from-to)382-390
Number of pages9
JournalClinical and Experimental Immunology
Volume46
Issue number2
Publication statusPublished - 1981

ASJC Scopus subject areas

  • Immunology

Fingerprint Dive into the research topics of 'Antibodies against human liver-specific protein (LSP) in acute and chronic viral heaptitis types A, B and non-A, non-B'. Together they form a unique fingerprint.

  • Cite this

    Meliconi, R., Baraldini, M., Stefanini, G. F., Facchini, A., Miglio, F., Bortolotti, F., Alberti, A., Realdi, G., & Amoroso, P. (1981). Antibodies against human liver-specific protein (LSP) in acute and chronic viral heaptitis types A, B and non-A, non-B. Clinical and Experimental Immunology, 46(2), 382-390.